QQ客服 官方微博 反馈留言

	Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study
	Huo, Y.; Jing, Z. C.; Zeng, X. F.; Liu, J. M.; Yu, Z. X.; Zhang, G. C.; Li, Y.; Wang, Y.; Ji, Q. S.; Zhu, P.
刊名	BMC CARDIOVASCULAR DISORDERS
	2016
卷号	16
关键词	Ambrisentan Chinese Exercise capacity Pulmonary arterial hypertension
DOI	10.1186/s12872-016-0361-9
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4689707
专题	山东大学
作者单位	1.Peking Univ, Affiliated Hosp 1, Cardiovasc, 8 Xishiku St, Beijing 100034, Peoples R China. 2.Chinese Acad Med Sci, FuWai Hosp
推荐引用方式 GB/T 7714	Huo, Y.,Jing, Z. C.,Zeng, X. F.,et al. Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study[J]. BMC CARDIOVASCULAR DISORDERS,2016,16.
APA	Huo, Y..,Jing, Z. C..,Zeng, X. F..,Liu, J. M..,Yu, Z. X..,...&Zheng, 更多.(2016).Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study.BMC CARDIOVASCULAR DISORDERS,16.
MLA	Huo, Y.,et al."Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study".BMC CARDIOVASCULAR DISORDERS 16(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。